ALK and anaplastic large cell lymphoma: Around 60% of ALK-negative cases show activation of JAK-STAT3 through mutations mainly in JAK1, JAK3, and STAT3, or rearrangements involving TYK2, ROS1, and FRK. This activation is not present in ALK-negative ALCL with DUSP22 rearrangements.